DAVID NELSON to Genotype
This is a "connection" page, showing publications DAVID NELSON has written about Genotype.
Connection Strength
0.221
-
All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study. Hepatology. 2015 Apr; 61(4):1127-35.
Score: 0.078
-
Prevalence and cardiometabolic correlates of ketohexokinase gene variants among UK Biobank participants. PLoS One. 2021; 16(2):e0247683.
Score: 0.030
-
Physical interactions reduce the power of natural selection in growing yeast colonies. Proc Natl Acad Sci U S A. 2018 11 06; 115(45):11448-11453.
Score: 0.025
-
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment. N Engl J Med. 2017 10 12; 377(15):1448-1455.
Score: 0.023
-
The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome. Cell Cycle. 2015; 14(18):2985-95.
Score: 0.019
-
CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant. Liver Int. 2013 Jan; 33(1):72-8.
Score: 0.017
-
Selective sweeps in growing microbial colonies. Phys Biol. 2012; 9(2):026008.
Score: 0.016
-
Reversal of sensorimotor gating abnormalities in Fmr1 knockout mice carrying a human Fmr1 transgene. Behav Neurosci. 2008 Dec; 122(6):1371-7.
Score: 0.013